Page last updated: 2024-08-24

triazoles and nifurtimox

triazoles has been researched along with nifurtimox in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's4 (40.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Atienza, J; Claramunt, RM; Elguero, J; Escario, JA; Gómez Barrio, A; Mester, B1
Caracelli, I; Cerecetto, H; Mester, B; Paulino, M; Stamato, FM1
Lazardi, K; Liendo, A; Molina, J; Payares, G; Perez, N; Piras, MM; Piras, R; Ryley, JF; Sanoja, C; Urbina, JA; Wincker, P1
Afonso, LC; Bahia, MT; Chiari, E; de Lana, M; Guedes, PM; Machado-Coelho, GL; Tafuri, WL; Urbina, JA; Veloso, VM1
Carlier, Y; Cencig, S; Coltel, N; Truyens, C1
Aldasoro, E; Cortes-Lletget, C; Espinosa, G; Gállego, M; Gascon, J; Muñoz, J; Oliveira, I; Pinazo, MJ; Posada, Ede J1
Bonhivers, M; Courtois, P; Dacheux, D; Dauchy, FA; Daulouède, S; Landrein, N; Lauruol, F; Robinson, DR; Vincendeau, P1
Bastos, MM; Batista, DDGJ; Bianco, MDCAD; Boechat, N; da Gama, ANS; da Silva, CF; da Silva, PB; de Oliveira, AP; Fontes, FV; Hoelz, LVB; Leite, DI; Peres, RB; Soeiro, MNC; Villar, JDF1
Bardach, A; Barreira, F; Ciapponi, A; Gascón, J; Molina, I; Morillo, C; Perelli, L; Prado, N; Riarte, A; Ribeiro, I; Sosa-Estani, S; Torrico, F; Villar, JC1
Acosta, N; Bobadilla, C; Escobar, P; Fernández, I; López, E; Ramírez, A; Yaluff, G1

Reviews

2 review(s) available for triazoles and nifurtimox

ArticleYear
Immunosuppression and Chagas disease: a management challenge.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:1

    Topics: Adult; Antiprotozoal Agents; Chagas Disease; Female; Humans; Immunocompromised Host; Male; Middle Aged; Nifurtimox; Nitroimidazoles; Opportunistic Infections; Triazoles; Trypanosoma cruzi

2013
Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.
    PLoS neglected tropical diseases, 2020, Volume: 14, Issue:8

    Topics: Adult; Cardiomyopathies; Chagas Disease; Databases, Factual; Humans; Nifurtimox; Nitroimidazoles; Patient Safety; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Trypanosoma cruzi

2020

Other Studies

8 other study(ies) available for triazoles and nifurtimox

ArticleYear
Research for new antichagasic drugs.
    Chemical & pharmaceutical bulletin, 1991, Volume: 39, Issue:8

    Topics: Animals; Azoles; Benzimidazoles; Chagas Disease; Imidazoles; Indazoles; Indoles; Mice; Nifurtimox; Nitro Compounds; Thiophenes; Triazoles; Trypanocidal Agents; Trypanosoma cruzi

1991
A new analogue of nifurtimox.
    Acta crystallographica. Section C, Crystal structure communications, 1996, May-15, Volume: 52 ( Pt 5)

    Topics: Antiprotozoal Agents; Crystallography, X-Ray; Imines; Molecular Conformation; Molecular Structure; Nifurtimox; Triazoles

1996
Cure of short- and long-term experimental Chagas' disease using D0870.
    Science (New York, N.Y.), 1996, Aug-16, Volume: 273, Issue:5277

    Topics: Animals; Base Sequence; Chagas Disease; Drug Administration Schedule; Ketoconazole; Molecular Sequence Data; Nifurtimox; Sterols; Time Factors; Triazoles; Trypanocidal Agents; Trypanosoma cruzi

1996
Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11

    Topics: Animals; Chagas Disease; Dogs; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Monocytes; Nifurtimox; Nitroimidazoles; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Trypanocidal Agents; Trypanosoma cruzi

2004
Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:6

    Topics: Amphotericin B; Animals; Chagas Disease; Disease Models, Animal; DNA, Protozoan; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Nifurtimox; Nitroimidazoles; Parasite Load; Parasitemia; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triazoles; Trypanocidal Agents; Trypanosoma cruzi

2012
Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
    PLoS neglected tropical diseases, 2016, Volume: 10, Issue:11

    Topics: 14-alpha Demethylase Inhibitors; Animals; Anti-Bacterial Agents; Cytokinesis; Disease Models, Animal; Doxycycline; Eflornithine; Ergosterol; Humans; Mice; Nifurtimox; Phenotype; RNA Interference; Sterol 14-Demethylase; Triazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

2016
New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
    Chemical biology & drug design, 2018, Volume: 92, Issue:3

    Topics: Animals; Cell Line; Cell Survival; Chagas Disease; Male; Mice; Nifurtimox; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi

2018
In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from Paraguay
    Biomedica : revista del Instituto Nacional de Salud, 2020, 12-02, Volume: 40, Issue:4

    Topics: Analysis of Variance; Genotype; Lethal Dose 50; Nifurtimox; Nitroimidazoles; Paraguay; Phenotype; Triazoles; Trypanocidal Agents; Trypanosoma cruzi

2020